Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.
As of February 2025 Novo Nordisk has a market cap of £300.92 Billion. This makes Novo Nordisk the world's 25th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Jan 31st, 2025 the market cap of Novo Nordisk was reported to be: